Following exciting advancements with new investments, scientific successes with our Mucosal Protection Platform, and clinical progress in our pipeline, we are happy to announce that we are further strengthening our senior leadership team.

We are pleased to announce the appointment of Clarissa Koch to Chief Research Officer, expanding her role to lead all Research functions at Leyden Labs. Clarissa has spearheaded Leyden Labs' Mucosal Protection Platform.

Jaap Goudsmit, co-founder of Leyden Labs, will now serve as Chief Scientist, advising on the company's scientific strategy.